Patients who were dependent on cannabis faced higher infection rates following minor knee and shoulder surgery.
The project will be the first in the world to investigate the feasibility of a medicinal cannabis clinical trial in this patient group.
The company's patented ‘cannabis-inspired compounds’ were effective in reducing motor symptoms.
A full health economic analysis hopes to show cannabis could be prescribed on the NHS at 'net-zero' cost.
Several phytocannabinoids, terpenes and flavonoids demonstrated neuroprotective properties.
The technology has the potential to make cannabis law-enforcement fairer.
Cannabis was safe, well-tolerated, and associated with meaningful reductions in pain.
The treatment improved quality of life and reduced behavioural psychological symptoms in patients.
Researchers in the UK are hoping to fund a major health economic study.
Arthritis patients reported significant improvements in symptoms after using CBD.